Printer Friendly

HOLOGIC ANNOUNCES IMPROVED SECOND QUARTER 1992 RESULTS

 HOLOGIC ANNOUNCES IMPROVED SECOND QUARTER 1992 RESULTS
 WALTHAM, Mass., April 30 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today announced its results for the second quarter ended March 31, 1992, reporting net income of $492,168 or 12 cents per share, compared with net income of $85,233 or 2 cents per share, for the second quarter of fiscal 1991. Second quarter revenues increased 54 percent to $6,535,210 from $4,247,752 for the second quarter of fiscal 1991 and increased 20 percent from $5,468,367 for the first quarter of fiscal 1992.
 Net income for the six months ended March 31, 1992 was $803,322, or 20 cents per share, compared with net income of $7,072 for the six months ended March 31, 1991. Total revenues increased 48 percent to $12,003,577 for the current six month period from $8,110,612 in 1991.
 "Our growth continues to be fueled by increasing sales of the QDR- 2000 Supine Lateral Bone Densitometer," said S. David Ellenbogen, president and CEO. "In addition, sales through our new subsidiaries in Belgium, France and Spain began this quarter and are expected to expand our presence in these countries significantly over the coming quarters."
 Hologic, Inc. develops, manufactures and markets proprietary X-ray systems. With more than 900 installations worldwide, the company's QDR X-ray bone densitometers are used for the precise measurement of bone density to assist in the diagnosis and monitoring of osteoporosis and other metabolic bone diseases. Osteoporosis, a condition characterized by decreased bone density and increased risk of fractures, occurs in at least one of three women over the age of 65.
 HOLOGIC, INC. AND SUBSIDIARIES
 Consolidated Statements of Income
 (Unaudited)
 Three Months Ended Six Months Ended
 3/31/92 3/31/91 3/31/92 3/31/91
 Revenues:
 Product sales $6,402,916 $3,489,308 $11,719,359 $6,559,825
 Research and
 development contract --- 554,007 --- 1,105,164
 Interest income 132,294 204,437 284,218 445,623
 Total $6,535,210 $4,247,752 $12,003,577 8,110,612
 Costs and Expenses:
 Cost of product
 sales 3,251,193 1,930,566 5,906,320 3,927,844
 Research and
 development 890,823 1,053,974 1,668,023 2,115,863
 Selling & marketing 846,666 547,016 1,799,896 1,125,992
 General and
 administrative 844,360 594,963 1,483,016 930,841
 Total 5,833,042 4,126,519 10,857,255 8,100,540
 Income before
 provision for
 income taxes 702,168 121,233 1,146,322 10,072
 Provision for
 income taxes 210,000 36,000 343,000 3,000
 Net income $492,168 $85,233 $803,322 $7,072
 Net income per common
 and common equivalent
 share:
 Primary 12 cents 2 cents 20 cents ---
 Weighted average number
 and common equivalent
 shares outstanding:
 Primary 4,087,315 4,042,575 4,060,051 4,068,370
 Hologic, Inc. And Subsidiaries Consolidated Balance Sheets
 Assets
 March 31, Sept. 30,
 1992 1991
 (Unaudited) (Audited)
 Current Assets:
 Cash and cash equivalents $1,970,765 $9,032,209
 Short-term investments 9,810,506 2,833,745
 Accounts receivable, less
 reserve of $125,000 4,798,585 3,431,287
 Inventories 3,026,057 2,894,246
 Prepaid expenses and other
 current assets 840,455 446,531
 Total current assets 20,446,368 18,638,018
 Property and Equipment, at cost:
 Equipment 1,312,299 1,211,037
 Furniture and fixtures 361,328 295,654
 Leasehold improvements 219,988 158,075
 Total 1,893,615 1,664,766
 Less accumulated depreciation
 and amortization 708,579 561,220
 Total 1,185,036 1,103,546
 Other assets, net 108,554 67,914
 Total $21,739,958 $19,809,478
 Liabilities and Stockholders' Equity
 Current Liabilities:
 Accounts payable $1,773,234 $1,129,450
 Accrued expenses 1,933,545 1,632,475
 Deferred revenue 515,881 373,354
 Total current liabilities 4,222,660 3,135,279
 Stockholders' Equity:
 Common stock, 1 cent par value -
 Authorized - 10 million shares
 Issued and outstanding -
 3,894,642 and 3,866,317 shares
 at March 31, 1992 and Sept. 30
 1991, respectively 38,946 38,663
 Capital in excess of par value 13,823,326 13,783,832
 Retained earnings 3,655,026 2,851,704
 Total stockholders' equity 17,517,298 16,674,199
 Total $21,739,958 $19,809,478
 -0- 4/30/92
 /CONTACT: S. David Ellenbogen, president, or Glenn Muir, vice president-finance, of Hologic, 617-890-2300/
 (HOLX) CO: Hologic, Inc. ST: Massachusetts IN: MTC SU: ERN


DH-SH -- NE001 -- 4731 04/30/92 08:04 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 30, 1992
Words:771
Previous Article:MAIL BOXES ETC. ANNOUNCES SALE OF MASTER LICENSES TO FRANCE, GERMANY AND THE UNITED KINGDOM
Next Article:PACIFICARE HEALTH SYSTEMS ANNOUNCES POSSIBLE PUBLIC OFFERING


Related Articles
HOLOGIC, INC. ANNOUNCES FIRST QUARTER 1992 RESULTS
HOLOGIC, INC. ANNOUNCES INCREASE IN THIRD QUARTER 1992 RESULTS
HOLOGIC, INC. ANNOUNCES YEAR-END AND FOURTH QUARTER 1992 RESULTS
HOLOGIC, INC. ANNOUNCES FIRST QUARTER 1993 RESULTS
HOLOGIC, INC. ANNOUNCES SECOND QUARTER 1993 RESULTS
HOLOGIC, INC. ANNOUNCES THIRD QUARTER 1993 RESULTS
HOLOGIC, INC. ANNOUNCES YEAR-END AND FOURTH QUARTER 1993 RESULTS
HOLOGIC, INC. RETURNS TO PROFITABILITY IN THE FIRST QUARTER OF FISCAL 1994
HOLOGIC Announces Record New Orders for DirectRay(R) Digital Radiography Products.
Hologic Announces Fourth Quarter and Fiscal 2001 Operating Results.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters